CRCW 最新10-Q变化
将 CRCW 最新的定期申报(10-K/10-Q)与上一份同类型申报逐章节对比:每个章节新增/删除的段落数与原文摘录。全部为确定性文本对比——无相似度评分、无方向判断、非投资建议。
对比:10-Q · 2026-08-19 与上一份 10-Q · 2026-07-13
| 章节 | 结果 | 新增 | 删除 | 微调 | 未变 |
|---|---|---|---|---|---|
| 管理层讨论与分析 | 文字有新增/删除 | +16 | −12 | ~1 | 7 |
| 市场风险(第3项) | 无段落级文字变化 | 0 | 0 | 0 | 1 |
| 控制与程序 | 文字有新增/删除 | 0 | 0 | ~2 | 0 |
| 风险因素 | 无段落级文字变化 | 0 | 0 | 0 | 10 |
| 其他信息 | 文字有新增/删除 | +2 | −1 | ~1 | 0 |
计数单位为段落;"新增/删除"指相对上一份文件新增/删除的文字,不含方向或好坏判断。
未列出(无法可靠提取或缺失):法律诉讼
代表性摘录
每个章节最多 5 条、每条约 300 字符的原文摘录,直接来自两份 SEC 文件。
管理层讨论与分析
相对上期新增的文字 · 来源:10-Q · 2026-08-19
On July 7, 2026, a Confirmation and Variation Agreement was executed to update the Frame Asset Purchase Agreement extending the Funding Requirement deadline by an additional 120 days and extinguishing the $1.00 Re-acquisition option.
The Asset Purchase Agreement further contains a buy-sell provision that may be triggered upon the occurrence of certain specified termination events, subject to applicable notice and cure periods and an overall five-year sunset following the closing of the transaction.
The Confirmation and Variation Agreement extinguishes this option.
The following terms are incorporated into the Confirmation and Variation Agreement:
1. Grant of Extension. The Seller hereby grants, and the Parties confirm, the 120-day extension of the Funding Deadline contemplated by Section 6.9(c) of the APA, such that the Funding Deadline is extended to the Extended Funding Deadline (the date 120 days after the original Funding Deadline), with…
相对上期删除的文字 · 来源:10-Q · 2026-07-13
On November 26, 2025, the Company entered into a Debt Conversion Agreement with AJB Capital Investments LLC. As of the closing, the Company had an outstanding principal balance and accrued but unpaid interest owed to AJB under various notes (collectively, the “Obligations”). Under the Agreement, the…
The parties acknowledge that, upon closing, all outstanding notes between the Parties will be cancelled and of no further force or effect, except for a single remaining obligation to be evidenced by an amended and restated promissory note (the “New Note”), which shall represent the sole remaining ou…
The Agreement included a leak-out provision under which, upon closing, AJB cannot sell, transfer, or otherwise dispose of Conversion Shares and Warrant Shares in the aggregate in excess of fifteen percent (15%) of the five-day volume-weighted average trading volume of the Company’s Common Stock, or …
Comparison of the three months ended March 31, 2026 and March 31, 2025
Revenues for the three months ended March 31, 2026 and 2025, were $4,047 and $2,856 respectively. The increase in revenue was due to increased demand for blockchain training services.
其他信息
相对上期新增的文字 · 来源:10-Q · 2026-08-19
During the quarter, the Company responded to comments from the Staff (“Staff”) of the Securities and Exchange Commission on the restatement of the financial statements included in the Form 10-K for the year ended December 31, 2024, including the impact on prior periods. In connection with this revie…
Subsequent to June 30, 2026, the Company has been responding to further comments from the Staff. That review remains ongoing.
相对上期删除的文字 · 来源:10-Q · 2026-07-13
During the quarter, the Company completed regulatory review of the restatement of the financial statements included in the Form 10-K for the year ended December 31, 2024, including the impact on prior periods. In connection with this review, the Company updated and enhanced its disclosures to reflec…
如何读 10-Q 的风险因素(第 1A 项)
10-Q 的风险因素章节有三种常见形态,本页按其一分类展示:
- 指向(pointer) — 公司仅声明"无重大变化"并指向年度 10-K 的完整风险因素;本季没有自己的风险文本可对比。
- 部分更新(partial) — 公司写明"除下述外无重大变化",只更新部分风险;摘录展示的正是本季新增的内容。
- 全文重述(restated) — 本季重新给出完整风险因素。若上一季只是"指向",则无法逐段对比,本页会将其标为"本季全文重述"。
这只是对文件结构的客观描述,不构成对风险高低的判断。
数据来自 SEC EDGAR 两份申报文件的文本级对比 · 确定性计算(无 AI 生成内容)· 仅供参考 · 非投资建议